Research — APO Research, Inc.

Pharma & Healthcare

Teicoplanin

Types: 200 mg · 400 mg
Applications: Adults · Children

5 editions20 December 2025

View 5 research editions

$2,950Single user · USD · Industry ResearchExplore product: Teicoplanin Compare research options for Teicoplanin

Pharma & Healthcare

Adrenocortical Carcinoma Drugs

Types: Chemotherapy · Targeted therapy
Applications: Research institute · Hospital · Clinic

5 editions22 December 2025

View 5 research editions

$3,450Single user · USD · Industry Growth & TrendsExplore product: Adrenocortical Carcinoma Drugs Compare research options for Adrenocortical Carcinoma Drugs

Pharma & Healthcare

C Difficile Infection Drug

Types: Fidaxomycin · Metronidazole · Vancomycin
Applications: Pre-treatment · Mid-term treatment · Others

5 editions22 December 2025

View 5 research editions

$3,950Single user · USD · Market StructureExplore product: C Difficile Infection Drug Compare research options for C Difficile Infection Drug

Pharma & Healthcare

Transferrins are glycoproteins that are often found in biological fluids of vertebrates. When a transferrin protein loaded with iron encounters a transferrin receptor on the surface of a cell, e.g., erythroid precursors in the bone marrow, it binds to it and is transported into the cell in a vesicle by receptor-mediated endocytosis. The pH of the vesicle is reduced by hydrogen ion pumps (H+ ATPases) to about 5.5, causing transferrin to release its iron ions. Iron release…

Types: Human Transferrin · Bovine Transferrin
Applications: Biopharmaceutical · Life Science Research · Others

5 editions28 December 2025

View 5 research editions

$3,450Single user · USD · Industry Growth & TrendsExplore product: Transferrin Compare research options for Transferrin

Pharma & Healthcare

Recombinant Antihemophilic Factor

Types: 200IU · 250IU
Applications: Hospital · Pharmacy

5 editions2 January 2026

View 5 research editions

$3,950Single user · USD · Market StructureExplore product: Recombinant Antihemophilic Factor Compare research options for Recombinant Antihemophilic Factor

Pharma & Healthcare

Lymphoma Drugs

Lymphoma is cancer that begins in infection-fighting cells of the immune system, called lymphocytes. These cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. When you have lymphoma, lymphocytes change and grow out of control.

Types: Oral · Injection
Applications: Hodgkin Lymphoma · Non-Hodgkin Lymphoma

5 editions20 December 2025

View 5 research editions